Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology.
View Top Employees from Aptevo Therapeutics Inc| Website | http://www.aptevotherapeutics.com |
| Ticker | APVO |
| Revenue | $23 million |
| Funding | $35 million |
| Employees | 64 (60 on RocketReach) |
| Founded | 2016 |
| Address | 2401 4th Avenue Suite 1050, Seattle, Washington 98101, US |
| Phone | (206) 838-0500 |
| Fax | (206) 838-0503 |
| Technologies |
JavaScript,
HTML,
Twitter
+17 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Biometrics, Healthcare, Biotechnology, Data and Analytics, Science and Engineering, Biopharma, Health Care |
| Web Rank | 4 Million |
| Keywords | Apvo, Induces At Low Nm Range, Aptevo Therapeutics, Aptevo, Aptevo Q2 Numbers |
| Competitors | Arcus Biosciences, Leap Therapeutics, Onconova Therapeutics, Puma Biotechnology, Inc., TG Therapeutics, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 6215 Companies, NAICS Code 325 Companies, NAICS Code 62 Companies, NAICS Code 3254 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies, NAICS Code 32 Companies |
Looking for a particular Aptevo Therapeutics Inc employee's phone or email?
Aptevo Therapeutics Inc Questions
The Aptevo Therapeutics Inc annual revenue was $23 million in 2024.
Daphne Taylor is the SVP and Chief Financial Officer of Aptevo Therapeutics Inc.
60 people are employed at Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is based in Seattle, Washington.
The NAICS codes for Aptevo Therapeutics Inc are [6215, 325, 62, 3254, 62151, 621, 32].
The SIC codes for Aptevo Therapeutics Inc are [283, 28, 2834, 80].
Top Aptevo Therapeutics Inc Employees
-
View
Jeff Lamothe
EVP and Chief Financial Officer at Aptevo Therapeutics Inc
Seattle, Washington, United States15+ -
21
-
55+
-
15+
-
45+
-
33
Related Companies
